Cargando…
Automatic Detection of the Circulating Cell-Free Methylated DNA Pattern of GCM2, ITPRIPL1 and CCDC181 for Detection of Early Breast Cancer and Surgical Treatment Response
SIMPLE SUMMARY: Breast cancer is a multifactorial disease that arises from the cumulative accumulation of acquired genetic as well as epigenetic alterations. Epigenetic alteration constitutes a molecular signature that can serve as a promising biomarker for early detection. In this study, we carry o...
Autores principales: | Wang, Sheng-Chao, Liao, Li-Min, Ansar, Muhamad, Lin, Shih-Yun, Hsu, Wei-Wen, Su, Chih-Ming, Chung, Yu-Mei, Liu, Cai-Cing, Hung, Chin-Sheng, Lin, Ruo-Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002961/ https://www.ncbi.nlm.nih.gov/pubmed/33803633 http://dx.doi.org/10.3390/cancers13061375 |
Ejemplares similares
-
GCM-SIV1.5: Optimal Tradeoff between GCM-SIV1 and GCM-SIV2
por: Zhang, Ping
Publicado: (2023) -
Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction
por: Chang, Shih-Ching, et al.
Publicado: (2020) -
Eps15 Homology Domain-Containing Protein 3 Hypermethylation as a Prognostic and Predictive Marker for Colorectal Cancer
por: Wang, Yu-Han, et al.
Publicado: (2021) -
SMAD3 Hypomethylation as a Biomarker for Early Prediction of Colorectal Cancer
por: Ansar, Muhamad, et al.
Publicado: (2020) -
Promoter hypomethylation and overexpression of TSTD1 mediate poor treatment response in breast cancer
por: Ansar, Muhamad, et al.
Publicado: (2022)